ArticleiLIVER2025

DGKH-PA-mTOR: A pharmacologically druggable metabolic axis underpinning tyrosine-kinase-inhibitor resistance in hepatocellular carcinoma.

Feifan Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.